California Oncologists Choose US Oncology for Payer Provider Partnership

June 24, 2011
The Woodlands, Texas-based US Oncology Inc., an integrated oncology company, announced today that the San Rafael-based Association of Northern

The Woodlands, Texas-based US Oncology Inc., an integrated oncology company, announced today that the San Rafael-based Association of Northern California Oncologists (ANCO) has selected Innovent Oncology as a preferred vendor for payer provider partnerships and front-end compliance models. ANCO says its role will be limited to informing, educating, and recommending that members proactively take advantage of front-end compliance programs such as Innovent Oncology to negotiate payer provider partnerships with major third-party payers. Innovent Oncology is a wholly-owned subsidiary of US Oncology designed by physicians and cancer care experts to expand patient access to high-quality, evidence-based medicine and proactive patient cancer care.

With a unique focus on supporting the entire care continuum for cancer patients, Innovent Oncology offers ANCO members a comprehensive, physician-driven cancer care solution that enhances the quality and consistency of patient care. ANCO physicians, working with Innovent Oncology, can access evidence-based treatment guidelines, proactive patient management services, and advance care planning to create value for patients. This collaborative program, coupled with managed care negotiations, aligns incentives to produce better outcomes and opportunities for enhanced reimbursement.

The foundation of Innovent Oncology's program is Level I Pathways, which are evidence-based guidelines used by hundreds of physicians in the United Network of US Oncology that offer ANCO physicians a more precise approach to cancer care compared to other generally accepted treatment guidelines. Developed by practicing community-based oncologists from the United Network of US Oncology, Level I Pathways assist physicians in making treatment decisions for the most commonly treated cancers and provide a consistent basis for delivering high-quality, evidence-based care. Pathways are documented through point-of-care decision support tools which provide a platform for standardization and outcomes measurement.


Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?